RO7105705

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO7105705, covering 2017-07-21 to 2017-07-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease [Phase 1]